NO20034561D0 - Use of cationic dextran derivatives for the protection of dose limiting organs - Google Patents

Use of cationic dextran derivatives for the protection of dose limiting organs

Info

Publication number
NO20034561D0
NO20034561D0 NO20034561A NO20034561A NO20034561D0 NO 20034561 D0 NO20034561 D0 NO 20034561D0 NO 20034561 A NO20034561 A NO 20034561A NO 20034561 A NO20034561 A NO 20034561A NO 20034561 D0 NO20034561 D0 NO 20034561D0
Authority
NO
Norway
Prior art keywords
protection
dose limiting
dextran derivatives
cationic dextran
limiting organs
Prior art date
Application number
NO20034561A
Other languages
Norwegian (no)
Other versions
NO20034561L (en
Inventor
Anders Holmberg
Jukka Olavi Hiltunen
Giovanni Paganelli
Marta Cremonesi
Original Assignee
Map Medical Technologies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Map Medical Technologies Oy filed Critical Map Medical Technologies Oy
Publication of NO20034561D0 publication Critical patent/NO20034561D0/en
Publication of NO20034561L publication Critical patent/NO20034561L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
NO20034561A 2001-04-11 2003-10-10 Use of cationic dextran derivatives for the protection of dose limiting organs NO20034561L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010764A FI20010764A0 (en) 2001-04-11 2001-04-11 Cationic dextran derivatives for use in renal protection
PCT/FI2002/000305 WO2002083154A1 (en) 2001-04-11 2002-04-11 Use of cationic dextran derivatives for protecting dose-limiting organs

Publications (2)

Publication Number Publication Date
NO20034561D0 true NO20034561D0 (en) 2003-10-10
NO20034561L NO20034561L (en) 2003-12-09

Family

ID=8560975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034561A NO20034561L (en) 2001-04-11 2003-10-10 Use of cationic dextran derivatives for the protection of dose limiting organs

Country Status (13)

Country Link
EP (1) EP1383517A1 (en)
JP (1) JP2004525181A (en)
KR (1) KR20040018350A (en)
BR (1) BR0208860A (en)
CA (1) CA2443052A1 (en)
EE (1) EE200300502A (en)
FI (1) FI20010764A0 (en)
HU (1) HUP0401386A3 (en)
IL (1) IL158153A0 (en)
NO (1) NO20034561L (en)
PL (1) PL363024A1 (en)
RU (1) RU2003132683A (en)
WO (1) WO2002083154A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010102066A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Dextran polymer powder for inhalation administration of pharmaceuticals
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
PT2611529T (en) 2010-09-03 2019-05-09 Bend Res Inc Spray-drying method
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
DE102014016901B4 (en) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Process for the production of new dextran derivatives as active ingredient carrier systems and their use
CN110023755A (en) * 2016-12-01 2019-07-16 诺伯特·格雷茨 Visible apparatus and method for institutional framework
JP2023516848A (en) * 2019-12-14 2023-04-21 チャウダリ，マヌ Preparation of polybasic drugs to reduce multi-organ toxicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (en) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-Amino acid mixtures for parenteral and oral use for kidney disorders
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
SE9803482D0 (en) * 1998-10-13 1998-10-13 Anders Holmberg Ion exchange tumor targeting (IETT)
EP1196154B1 (en) * 1999-07-16 2006-09-13 Mallinckrodt, Inc. Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine

Also Published As

Publication number Publication date
HUP0401386A3 (en) 2005-06-28
BR0208860A (en) 2004-10-19
PL363024A1 (en) 2004-11-15
JP2004525181A (en) 2004-08-19
CA2443052A1 (en) 2002-10-24
NO20034561L (en) 2003-12-09
HUP0401386A2 (en) 2004-12-28
IL158153A0 (en) 2004-03-28
FI20010764A0 (en) 2001-04-11
KR20040018350A (en) 2004-03-03
WO2002083154A1 (en) 2002-10-24
EE200300502A (en) 2003-12-15
EP1383517A1 (en) 2004-01-28
RU2003132683A (en) 2005-04-10

Similar Documents

Publication Publication Date Title
CY2019030I1 (en) RAPAMYCIN DERIVATIVE FOR THE THERAPEUTIC TREATMENT OF LUNG CANCER
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20025792L (en) Quinazoline derivatives for the treatment of tumors
NO20013380D0 (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
NO20033594L (en) Phenethanolamine derivatives for the treatment of respiratory diseases
DE60009147D1 (en) ADMANTAN DERIVATIVES
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
CY2014019I1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
NO20021400D0 (en) Therapeutic conazoline derivatives
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20042140L (en) Therapeutic quionolone compounds with 5-HT anatagonistic properties
NO20042635L (en) 5-Sulfanyl-HH-1,2,4-triazole derivatives and their use as medicine
NO20031615D0 (en) Pyrazole derivatives for the treatment of viral diseases
NO20034780L (en) Combination antiangiogenic therapy for the treatment of cancer
NO20040516L (en) Combination therapy for the treatment of cancer.
DE60013127D1 (en) 5-PHENYL-PYRIMIDINE DERIVATIVES
IS6917A (en) Epothilone derivatives for the treatment of difficult tumors
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
NO20034561D0 (en) Use of cationic dextran derivatives for the protection of dose limiting organs
DE60025918D1 (en) 4-PHENYL-PYRIMIDINE DERIVATIVES
NO20042640L (en) Process for the preparation of echinocandin derivatives
NO20020784L (en) Medication for the treatment of fractures
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
EE200300466A (en) Use of pyridoindolone derivatives in the preparation of medicaments
NO20041320L (en) Use of specific dose of fondaparinux sodium for the treatment of ACS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application